Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Genomic predictors of treatment response in prostate cancer

Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada
Genomic predictors of treatment response in prostate cancer ( Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada )
4 Jul 2017

Synthetic lethality as a basis to select drug combinations

Prof René Bernards - Netherlands Cancer Institute, Amsterdam, Holland
Synthetic lethality as a basis to select drug combinations ( Prof René Bernards - Netherlands Cancer Institute, Amsterdam, Holland )
4 Jul 2017

Genomic analysis of childhood tumours; biological and therapeutic implications

Dr Peter Lichter - German Cancer Research Center (DKFZ), Heidelberg, Germany
Genomic analysis of childhood tumours; biological and therapeutic implications ( Dr Peter Lichter - German Cancer Research Center (DKFZ), Heidelberg, Germany )
4 Jul 2017

Patient-specific peptide vaccines

Prof Hans-Georg Rammensee - University of Tübingen, Tübingen, Germany
Patient-specific peptide vaccines ( Prof Hans-Georg Rammensee - University of Tübingen, Tübingen, Germany )
4 Jul 2017

Proteogenomics in cancer research

Dr Henry Rodriguez - National Cancer Institute (NIH), Bethesda, USA
Proteogenomics in cancer research ( Dr Henry Rodriguez - National Cancer Institute (NIH), Bethesda, USA )
4 Jul 2017

Novel models to personalise cancer therapeutics

Dr Olli Kallioniemi - Karolinska Institutet, Stockholm, Sweden
Novel models to personalise cancer therapeutics ( Dr Olli Kallioniemi - Karolinska Institutet, Stockholm, Sweden )
4 Jul 2017

The Umberto Veronesi Milan Breast Cancer Conference

Dr Paolo Veronesi - European Institute of Oncology, Milan, Italy
The Umberto Veronesi Milan Breast Cancer Conference ( Dr Paolo Veronesi - European Institute of Oncology, Milan, Italy )
28 Jun 2017

Latest maintenance strategies in multiple myeloma

Prof Guillermo Ruiz-Arguelles and Prof McCarthy
Latest maintenance strategies in multiple myeloma ( Prof Guillermo Ruiz-Arguelles and Prof McCarthy )
25 Jun 2017

Lenalidomide with CD19 antibodies in L-MIND

Dr Kami Maddocks - Ohio State University, Columbus, USA
Lenalidomide with CD19 antibodies in L-MIND ( Dr Kami Maddocks - Ohio State University, Columbus, USA )
25 Jun 2017

Denosumab or zoledronic acid for bone disease in multiple myeloma

Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece
Denosumab or zoledronic acid for bone disease in multiple myeloma ( Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece )
25 Jun 2017

Extended followup indicates daratumumab with bortezomib and dexamethasone for relapsed MM

Prof Katja Weisel - University of Tübingen, Tübingen, Germany
Extended followup indicates daratumumab with bortezomib and dexamethasone for relapsed MM ( Prof Katja Weisel - University of Tübingen, Tübingen, Germany )
24 Jun 2017

Impact of mutational profile at diagnosis for MDS/CML

Dr Guillermo Montalban Bravo - MD Anderson Cancer Center, Houston, USA
Impact of mutational profile at diagnosis for MDS/CML ( Dr Guillermo Montalban Bravo - MD Anderson Cancer Center, Houston, USA )
24 Jun 2017